UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adequacy of implantable cardioverter-defibrillator lead placement for tachyarrhythmia detection by sinus rhythm electrogram amplitude

The American journal of cardiology, 1995-12, Vol.76 (16), p.1162-1166

1995

Volltextzugriff (PDF)

Psychosocial Care for Injured Children: Worldwide Survey among Hospital Emergency Department Staff

The Journal of pediatrics, 2016-03, Vol.170, p.227-233.e6

2016

Volltextzugriff (PDF)

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

Maturitas, 2014-03, Vol.77 (3), p.274-281

2014

Volltextzugriff (PDF)

Tolterodine Extended Release Is Efficacious in Continent and Incontinent Subjects with Overactive Bladder

Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.488-493

2008

Volltextzugriff (PDF)

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Journal of the American College of Cardiology, 2013-02, Vol.61 (8), p.872-879

2013

Volltextzugriff (PDF)

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Journal of the American College of Cardiology, 2012-04, Vol.59 (14), p.1304-1311

2012

Volltextzugriff (PDF)

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

The Lancet (British edition), 2009-09, Vol.374 (9694), p.989-997

2009

Volltextzugriff (PDF)

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Journal of the American College of Cardiology, 2007-07, Vol.50 (1), p.40-47

2007

Volltextzugriff (PDF)

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2012-05, Vol.59 (20), p.1785-1795

2012

Volltextzugriff (PDF)

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

The Lancet (British edition), 2003-09, Vol.362 (9386), p.777-781

2003

Volltextzugriff (PDF)

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Journal of the American College of Cardiology, 2006-05, Vol.47 (10), p.1997-2004

2006

Volltextzugriff (PDF)

Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction

Journal of the American College of Cardiology, 2001-10, Vol.38 (4), p.1002-1006

2001

Volltextzugriff (PDF)

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Lancet neurology, 2014-05, Vol.13 (5), p.461-471

2014

Volltextzugriff (PDF)

Assessing surgical site infection risk factors using electronic medical records and text mining

American journal of infection control, 2014-03, Vol.42 (3), p.333-336

2014

Volltextzugriff (PDF)

A semi-quantitative technique to assess excursion of the flexor hallucis longus

Foot and ankle surgery, 2019-08, Vol.25 (4), p.534-537

2019

Volltextzugriff (PDF)

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

The American heart journal, 2006-07, Vol.152 (1), p.86-92

2006

Volltextzugriff (PDF)

Increased Platelet Reactivity and Circulating Monocyte-Platelet Aggregates in Patients With Stable Coronary Artery Disease

Journal of the American College of Cardiology, 1998-02, Vol.31 (2), p.352-358

1998

Volltextzugriff (PDF)

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

Journal of the American College of Cardiology, 2011-05, Vol.57 (19), p.1908-1916

2011

Volltextzugriff (PDF)

Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel: Insights From the ELEVATE-TIMI 56 Trial

Journal of the American College of Cardiology, 2014-07, Vol.64 (4), p.361-368

2014

Volltextzugriff (PDF)

A standardized protocol using clinical adjudication to define true infection status in patients presenting to the emergency department with suspected infections and/or sepsis

Diagnostic microbiology and infectious disease, 2024-09, Vol.110 (1), p.116382, Article 116382

2024

Volltextzugriff (PDF)

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2008-12, Vol.52 (24), p.2000-2007

2008

Volltextzugriff (PDF)

Quantitative relationship of first metatarsophalangeal head morphology to hallux rigidus and hallux valgus

Foot and ankle surgery, 2018-10, Vol.24 (5), p.435-439

2018

Volltextzugriff (PDF)

Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2016-12, Vol.123 (12), p.2554-2570

2016

Volltextzugriff (PDF)

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Biological psychiatry (1969), 2016-01, Vol.79 (2), p.136-148

2016

Volltextzugriff (PDF)

Frequency of Aspirin Resistance in a Community Hospital

The American journal of cardiology, 2006-09, Vol.98 (5), p.577-579

2006

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adequacy of implantable cardioverter-defibrillator lead placement for tachyarrhythmia detection by sinus rhythm electrogram amplitude

Psychosocial Care for Injured Children: Worldwide Survey among Hospital Emergency Department Staff

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

Tolterodine Extended Release Is Efficacious in Continent and Incontinent Subjects with Overactive Bladder

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Assessing surgical site infection risk factors using electronic medical records and text mining

A semi-quantitative technique to assess excursion of the flexor hallucis longus

Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program

Increased Platelet Reactivity and Circulating Monocyte-Platelet Aggregates in Patients With Stable Coronary Artery Disease

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel: Insights From the ELEVATE-TIMI 56 Trial

A standardized protocol using clinical adjudication to define true infection status in patients presenting to the emergency department with suspected infections and/or sepsis

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Quantitative relationship of first metatarsophalangeal head morphology to hallux rigidus and hallux valgus

Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

Frequency of Aspirin Resistance in a Community Hospital

Aktive Filter

Suchergebnisse filtern